MARC-GARCIA PIERRE-LOUIS: Open Payments
NPI 1831587559 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 48 payments from 9 companies in 2025. Trend: 2023 $1,497 · 2024 $922 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $464 |
| Axsome Therapeutics, Inc. | 4 | $400 |
| Teva Pharmaceuticals USA, Inc. | 12 | $266 |
| Alkermes, Inc. | 8 | $167 |
| Vanda Pharmaceuticals Inc. | 2 | $126 |
| E.R. Squibb & Sons, L.L.C. | 2 | $120 |
| ABBVIE INC. | 4 | $108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $48 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
Products named: CAPLYTA, Auvelity, UZEDY, LYBALVI, FANAPT, COBENFY, AUSTEDO XR, VRAYLAR.
Industry payments across FL — which companies pay providers there.
